ESC Working Group on Myocardial Function Position Paper: How to study the right ventricle in experimental models

European Journal of Heart Failure

Volumn 16, Issue 5, 2014, Pages 509-518

  Leite Moreira, Adelino F ^a   Lourenço, André P ^a   Balligand, Jean Luc ^b   Bauersachs, Johann ^c   Clerk, Angela ^d   De Windt, Leon J ^e   Heymans, Stephane ^e   Hilfiker Kleiner, Denise ^c   Hirsch, Emilio ^f   Iaccarino, Guido ^g   Kaminski, Karol A ^h   Knöll, Ralph ⁱ   Mayr, Manuel ^j   Tarone, Guido ^f   Thum, Thomas ^c,i   Tocchetti, Carlo G ^k  

^a University of Porto   (Portugal)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF READING   (United Kingdom)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF SALERNO   (Italy)

^h MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k Clinica Montevergine   (Italy)

more..

Author keywords

Cardiac imaging; Chronic overload; Experimental myocardial preparations; Functional evaluation; Haemodynamics; Right ventricle function

Indexed keywords

CARDIOMYOPATHY; EX VIVO STUDY; EXERCISE; EXPERIMENTAL MODEL; GENDER; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HUMAN; HYPOXEMIA; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; BIOLOGICAL MODEL; HEART MUSCLE CELL; HEART VENTRICLE; HEMODYNAMICS; METABOLISM; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; PROGNOSIS; RESEARCH DESIGN; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 84899480805     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.66     Document Type: Review

References (68)

1. Haddad F, Couture P, Tousignant C, Denault AY,. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg 2009; 108: 407-421.
2. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB,. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114: 1883-1891.
3. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr,. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999; 1: 7-21.
4. Saouti N, Westerhof N, Helderman F, Marcus JT, Boonstra A, Postmus PE, Vonk-Noordegraaf A,. Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med 2010; 182: 1315-1320.
5. Ventetuolo CE, Ouyang P, Bluemke DA, Tandri H, Barr RG, Bagiella E, Cappola AR, Bristow MR, Johnson C, Kronmal RA, Kizer JR, Lima JA, Kawut SM,. Sex hormones are associated with right ventricular structure and function: the MESA-right ventricle study. Am J Respir Crit Care Med 2011; 183: 659-667.
6. Kawut SM, Al-Naamani N, Agerstrand C, Rosenzweig EB, Rowan C, Barst RJ, Bergmann S, Horn EM,. Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest 2009; 135: 752-759.
7. Huez S, Faoro V, Guenard H, Martinot JB, Naeije R,. Echocardiographic and tissue Doppler imaging of cardiac adaptation to high altitude in native highlanders versus acclimatized lowlanders. Am J Cardiol 2009; 103: 1605-1609.
8. Brimioulle S, Wauthy P, Ewalenko P, Rondelet B, Vermeulen F, Kerbaul F, Naeije R,. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003; 284: H1625-H1630.
9. Faoro V, Boldingh S, Moreels M, Martinez S, Lamotte M, Unger P, Brimioulle S, Huez S, Naeije R,. Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia. Chest 2009; 135: 1215-1222.
10. Naeije R, Chesler N,. Pulmonary circulation at exercise. Comp Physiol 2012; 2: 711-741.
11. Aaron CP, Tandri H, Barr RG, Johnson WC, Bagiella E, Chahal H, Jain A, Kizer JR, Bertoni AG, Lima JA, Bluemke DA, Kawut SM,. Physical activity and right ventricular structure and function: the MESA-right ventricle study. Am J Respir Crit Care Med 2011; 183: 396-404.
12. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidbuchel H, Prior DL,. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012; 33: 998-1006.
13. Krol W, Braksator W, Kasprzak JD, Kuch M, Mamcarz A, Chybowska B, Krysztofiak H, Dluzniewski M,. The influence of extreme mixed exertion load on the right ventricular dimensions and function in elite athletes: a tissue Doppler study. Echocardiography 2011; 28: 753-760.
14. Handoko ML, de Man FS, Happe CM, Schalij I, Musters RJ, Westerhof N, Postmus PE, Paulus WJ, van der Laarse WJ, Vonk-Noordegraaf A,. Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation 2009; 120: 42-49.
15. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grunig E,. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114: 1482-1489.
16. Hopkins WE,. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis 2005; 16: 19-25.
17. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF,. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009; 135: 794-804.
18. Calcutteea A, Chung R, Lindqvist P, Hodson M, Henein MY,. Differential right ventricular regional function and the effect of pulmonary hypertension: three-dimensional echo study. Heart 2011; 97: 1004-1011.
19. Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra ML, Beltran M, Guerrero ML,. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994; 89: 1733-1744.
20. van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, Boonstra A, Marques KM, Westerhof N, Vonk-Noordegraaf A,. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58: 2511-2519.
21. Wauthy P, Pagnamenta A, Vassalli F, Naeije R, Brimioulle S,. Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol 2004; 286: H1441-H1447.
22. Stevens GR, Garcia-Alvarez A, Sahni S, Garcia MJ, Fuster V, Sanz J,. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging 2012; 5: 378-387.
23. Vacchi-Suzzi C, Hahne F, Scheubel P, Marcellin M, Dubost V, Westphal M, Boeglen C, Buchmann-Moller S, Cheung MS, Cordier A, De Benedetto C, Deurinck M, Frei M, Moulin P, Oakeley E, Grenet O, Grevot A, Stull R, Theil D, Moggs JG, Marrer E, Couttet P,. Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions. PLoS One 2013; 8: e52442.
24. Wong YY, Ruiter G, Lubberink M, Raijmakers PG, Knaapen P, Marcus JT, Boonstra A, Lammertsma AA, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A,. Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization. Circ Heart Fail 2011; 4: 700-706.
25. Tuxworth WJ Jr, Shiraishi H, Moschella PC, Yamane K, McDermott PJ, Kuppuswamy D,. Translational activation of 5â€-TOP mRNA in pressure overload myocardium. Basic Res Cardiol 2008; 103: 41-53.
26. Greyson CR, Schwartz GG, Lu L, Ye S, Helmke S, Xu Y, Ahmad H,. Calpain inhibition attenuates right ventricular contractile dysfunction after acute pressure overload. J Mol Cell Cardiol 2008; 44: 59-68.
27. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK,. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF- 1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008; 294: H570-H578.
28. Santulli G, Trimarco B, Iaccarino G,. G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev 2013; 20: 5-12.
29. Bogaard HJ, Natarajan R, Mizuno S, Abbate A, Chang PJ, Chau VQ, Hoke NN, Kraskauskas D, Kasper M, Salloum FN, Voelkel NF,. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med 2010; 182: 652-660.
30. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W,. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806-814.
31. Fabritz L, Hoogendijk MG, Scicluna BP, van Amersfoorth SC, Fortmueller L, Wolf S, Laakmann S, Kreienkamp N, Piccini I, Breithardt G, Noppinger PR, Witt H, Ebnet K, Wichter T, Levkau B, Franke WW, Pieperhoff S, de Bakker JM, Coronel R, Kirchhof P,. Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J Am Coll Cardiol 2011; 57: 740-750.
32. Lodder EM, Rizzo S,. Mouse models in arrhythmogenic right ventricular cardiomyopathy. Front Physiol 2012; 3: 221.
33. Marcus JT, Gan CT, Zwanenburg JJ, Boonstra A, Allaart CP, Gotte MJ, Vonk-Noordegraaf A,. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008; 51: 750-757.
34. Hardziyenka M, Surie S, de Groot JR, de Bruin-Bon HA, Knops RE, Remmelink M, Yong ZY, Baan J Jr, Bouma BJ, Bresser P, Tan HL,. Right ventricular pacing improves haemodynamics in right ventricular failure from pressure overload: an open observational proof-of-principle study in patients with chronic thromboembolic pulmonary hypertension. Europace 2011; 13: 1753-1759.
35. Handoko ML, Lamberts RR, Redout EM, de Man FS, Boer C, Simonides WS, Paulus WJ, Westerhof N, Allaart CP, Vonk-Noordegraaf A,. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am J Physiol Heart Circ Physiol 2009; 297: H1752-H1759.
36. Lourenco AP, Roncon-Albuquerque R Jr, Bras-Silva C, Faria B, Wieland J, Henriques-Coelho T, Correia-Pinto J, Leite-Moreira AF,. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 2006; 291: H1587-H1594.
37. Lourenco AP, Vasques-Novoa F, Fontoura D, Bras-Silva C, Roncon-Albuquerque R Jr, Leite-Moreira AF,. A Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats. J Nutr 2011; 141: 1954-1960.
38. Lourenco AP, Fontoura D, Henriques-Coelho T, Leite-Moreira AF,. Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol 2012; 155: 350-361.
39. Naeije R, van de Borne P,. Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J 2009; 34: 792-794.
40. Lahm T, McCaslin CA, Wozniak TC, Ghumman W, Fadl YY, Obeidat OS, Schwab K, Meldrum DR,. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 2010; 56: 1435-1446.
41. Lourenco AP, Vasques-Novoa F, Oliveira-Pinto J, Fontoura D, Roncon-Albuquerque R Jr, Leite-Moreira AF,. Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension. Intensive Care Med 2012; 38: 1050-1060.
42. Galie N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, Espinola-Zavaleta N, Rocchi G, Manes A, Frantz R, Kurzyna M, Nagueh SF, Barst R, Channick R, Dujardin K, Kronenberg A, Leconte I, Rainisio M, Rubin L,. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003; 41: 1380-1386.
43. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA,. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 2005; 11: 214-222.
44. Piao L, Fang YH, Cadete VJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J, Lopaschuk GD, Archer SL,. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl) 2010; 88: 47-60.
45. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB,. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713; quiz 86-88.
46. Urboniene D, Haber I, Fang YH, Thenappan T, Archer SL,. Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2010; 299: L401-L412.
47. Thibault HB, Kurtz B, Raher MJ, Shaik RS, Waxman A, Derumeaux G, Halpern EF, Bloch KD, Scherrer-Crosbie M,. Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension. Circ Cardiovasc Imaging 2010; 3: 157-163.
48. Reddy S, Zhao M, Hu DQ, Fajardo G, Katznelson E, Punn R, Spin JM, Chan FP, Bernstein D,. Physiologic and molecular characterization of a murine model of right ventricular volume overload. Am J Physiol Heart Circ Physiol 2013; 304: H1314-H1327.
49. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M,. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006; 129: 1313-1321.
50. Kawut SM, Barr RG, Johnson WC, Chahal H, Tandri H, Jain A, Bristow MR, Kizer JR, Bagiella E, Lima JA, Bluemke DA,. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study. Biomarkers 2010; 15: 731-738.
51. Tutarel O, Dangwal S, Bretthauer J, Westhoff-Bleck M, Roentgen P, Anker SD, Bauersachs J, Thum T,. Circulating miR-423-5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. Int J Cardiol 2013; 167: 63-66.
52. Piao L, Fang YH, Parikh KS, Ryan JJ, D'Souza KM, Theccanat T, Toth PT, Pogoriler J, Paul J, Blaxall BC, Akhter SA, Archer SL,. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. Circulation 2012; 126: 2859-2869.
53. Bartelds B, Borgdorff MA, Smit-van Oosten A, Takens J, Boersma B, Nederhoff MG, Elzenga NJ, van Gilst WH, De Windt LJ, Berger RM,. Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load. Eur J Heart Fail 2011; 13: 1275-1282.
54. Schwenke DO, Pearson JT, Mori H, Shirai M,. Long-term monitoring of pulmonary arterial pressure in conscious, unrestrained mice. J Pharmacol Toxicol Methods 2006; 53: 277-283.
55. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F,. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005; 115: 2811-2821.
56. Correia-Pinto J, Henriques-Coelho T, Magalhaes S, Leite-Moreira AF,. Pattern of right ventricular pressure fall and its modulation by afterload. Physiol Res 2004; 53: 19-26.
57. Herberg U, Gatzweiler E, Breuer T, Breuer J,. Ventricular pressure-volume loops obtained by 3D real-time echocardiography and mini pressure wire-a feasibility study. Clin Res Cardiol 2013; 102: 427-438.
58. Sanz J, Garcia-Alvarez A, Fernandez-Friera L, Nair A, Mirelis JG, Sawit ST, Pinney S, Fuster V,. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 2012; 98: 238-243.
59. Bishop A, White P, Oldershaw P, Chaturvedi R, Brookes C, Redington A,. Clinical application of the conductance catheter technique in the adult human right ventricle. Int J Cardiol 1997; 58: 211-221.
60. White PA, Redington AN,. Right ventricular volume measurement: can conductance do it better? Physiol Meas 2000; 21: R23-R41.
61. Faber MJ, Dalinghaus M, Lankhuizen IM, Steendijk P, Hop WC, Schoemaker RG, Duncker DJ, Lamers JM, Helbing WA,. Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am J Physiol Heart Circ Physiol 2006; 291: H1580-H1586.
62. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF,. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1013-L1032.
63. Gomez-Arroyo JG, Farkas L, Alhussaini AA, Farkas D, Kraskauskas D, Voelkel NF, Bogaard HJ,. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol 2012; 302: L363-L369.
64. Lorenz CH, Walker ES, Graham TP Jr, Powers TA,. Right ventricular performance and mass by use of cine MRI late after atrial repair of transposition of the great arteries. Circulation 1995; 92 (9 Suppl): II233-II239.
65. Watts JA, Marchick MR, Kline JA,. Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension. J Card Fail 2010; 16: 250-259.
66. Kondo RP, Dederko DA, Teutsch C, Chrast J, Catalucci D, Chien KR, Giles WR,. Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J Physiol 2006; 571: 131-146.
67. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bjorling L, Ponten F,. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010; 28: 1248-1250.
68. Barallobre-Barreiro J, Didangelos A, Schoendube FA, Drozdov I, Yin X, Fernandez-Caggiano M, Willeit P, Puntmann VO, Aldama-Lopez G, Shah AM, Domenech N, Mayr M,. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 2012; 125: 789-802.